Download PDF
Phlebologie 2024; 53(02): 71-77
DOI: 10.1055/a-1968-9870
Curriculare Fortbildung

Sklerosierungstherapie von retikulären und Besenreiservarizen

Sclerotherapy of Reticular Varicosis and Spider Veins
Andreas H. Dietrich
,
Jasmin Schießl
› Further Information
    Permissions and Reprints

Dieser Artikel behandelt die leitliniengerechte Indikationsstellung, Behandlungsabläufe, Behandlungsmöglichkeiten sowie die Vermeidung von Komplikationen bei der Sklerosierungstherapie von retikulären und Besenreiservarizen in der phlebologischen Praxis.

Abstract

This article discusses the guideline-based indications, treatment options and procedures as well as avoidance of complication in sclerotherapy of reticular and spider varicose veins in daily practice.

Schlüsselwörter

retikuläre Varizen - Besenreiser - Besenreiservarizen - Sklerotherapie - Schaumsklerosierung - Flüssigsklerosierung

Keywords

varicose veins - reticular varicosis - spider veins - sclerotherapy - foam sclerotherapy - liquid sclerotherapy


Publication History

Article published online:
14 February 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Rabe E, Pannier-Fischer F, Bromen K. et al. Bonner Venenstudie der Deutschen Gesellschaft für Phlebologie. Phlebologie 2003; 32 DOI: 10.1055/s-0037-1617353.
    Google Scholar
  • 2 Lurie F, Passman M, Meisner M. et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord 2020; 8 DOI: 10.1016/j.jvsv.2019.12.075.
    Google Scholar
  • 3 Marsden G, Perry M, Kelley K. et al. Diagnosis and management of varicose veins in the legs: Summary of NICE guidance. BMJ (Online) 2013; 347 DOI: 10.1136/bmj.f4279.
    Google Scholar
  • 4 Rabe E, Breu FX, Flessenkämper I. et al. Leitlinie Sklerosierungsbehandlung der Varikose. Der Hautarzt 2021; 72: 50-64 DOI: 10.1007/s00105-020-04707-y.
    Google Scholar
  • 5 De Maeseneer MG, Kakkos SK, Aherne T. et al. Editor’s Choice – European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. European Journal of Vascular and Endovascular Surgery 2022; 63 DOI: 10.1016/j.ejvs.2021.12.024.
    Google Scholar
  • 6 Waldhausen P. Verödungstherapie, Geschichte und Entwicklung der Verödungstherapie. In: Varikose: Diagnostik-Therapie-Begutachtung. Springer-Verlag; 2010: 267 ff
    Google Scholar
  • 7 Kreussler: Fachinformationen Aethoxysklerol ® 0,25% / 0,5% / 1% / 2% /3% Stand August 2015, Chemische Fabrik Kreussler & Co GmbH.
    Google Scholar
  • 8 Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatologic Surgery 2001; 27 DOI: 10.1046/j.1524-4725.2001.00192.x.
    Google Scholar
  • 9 Rathbun S, Norris A, Stoner J. Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders. Phlebology 2012; 27: 105-117
    Google Scholar
  • 10 Hach W. Sklerosierung. In: VenenChirurgie: operative, interventionelle und konservative Aspekte. Schattauer; 2013: 43-50
    Google Scholar
  • 11 Deutsche Gesellschaft für Angiologie. S2k-Leitlinie „Diagnostik und Therapie der Venenthrombose und der Lungenembolie. 2023 https://register.awmf.org/de/leitlinien/detail/065–002 2023
    Google Scholar
  • 12 Rabe E, Breu FX, Cavezzi A. et al. European guidelines for sclerotherapy in chronic venous disorders. Phlebology 2014; 29 DOI: 10.1177/0268355513483280.
    Google Scholar
  • 13 Prophylaxe der venösen Thromboembolie (VTE). Vasa 2016; 45: 1-88 DOI: 10.1024/0301-1526/a000580.
    Google Scholar
  • 14 Rabe E, Pannier F. Indications, contraindications and performance: European Guidelines for Sclerotherapy in Chronic Venous Disorders*. Phlebology 2014; 29 DOI: 10.1177/0268355514528127.
    Google Scholar
  • 15 Bihari I, Magyar É. Reasons for ulceration after injection treatment of telangiectasia. Dermatologic Surgery 2001; 27 DOI: 10.1046/j.1524-4725.2001.00298.x.
    Google Scholar
  • 16 Parsi K. Paradoxical embolism, stroke and sclerotherapy. Phlebology 2012; 27 DOI: 10.1258/phleb.2011.010098.
    Google Scholar
  • 17 Zouitina Y, Terrier M, Hyra M. et al. Prolonged acute migraine with aura and reversible brain MRI abnormalities after liquid sclerotherapy. Journal of Headache and Pain 2014; 15 DOI: 10.1186/1129-2377-15-41.
    Google Scholar
  • 18 Goldman MP, Sadick NS, Weiss RA. Cutaneous Necrosis, Telangiectatic Matting, and Hyperpigmentation following Sclerotherapy Etiology, Prevention, and Treatment. Dermatologic Surgery 1995; 21 DOI: 10.1111/j.1524-4725.1995.tb00107.x.
    Google Scholar
  • 19 Scultetus AH, Villavicencio JL, Kao TC. et al. Microthrombectomy reduces postsclerotherapy pigmentation: Multicenter randomized trial. Journal of Vascular Surgery 2003; 38 (05) 896-903
    Google Scholar
  • 20 Miyake RK, Ramacciotti E. Cryo-laser and cryo-sclerotherapy guided by augmented reality for telangiectasias, feeder, and small varicose vein treatment–The CLaCS technique white paper report.
    Google Scholar